Get started
Author

Palak Y. Patel

Observed names: P. Patel, Palak Patel, Patel, Palak
Observed institutions: Intermountain Healthcare, Centers for Disease Control and Prevention, National Institutes of Health, Hartford Hospital, Beth Israel Deaconess Medical Center, Regenstrief Institute, Kaiser Permanente, Harvard University, Massachusetts College of Pharmacy and Health Sciences, National Center for Immunization and Respiratory Diseases, Augusta University, Columbia University Irving Medical Center, John H. Stroger, Jr. Hospital of Cook County, MedStar Georgetown University Hospital, Massachusetts General Hospital, Centers for Disease Control and Prevention, Kaiser Permanente Center for Health Research, National Institute of Allergy and Infectious Diseases, Centers for Disease Control and Prevention, Ocean Medical Center, Hackensack Meridian Health, CFD Research Corporation (United States), Baylor Scott & White Health, Cook County Health and Hospitals System, Oak Ridge Institute for Science and Education, Indiana University School of Medicine, Kaiser Permanente Northern California, HealthPartners
ORCID: 0000-0001-9341-8091
Observed ORCID: 0000-0001-9341-8091
OpenAlex ID: A5103103510
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings
2021 · Mark G. Thompson, Edward Stenehjem, et al. · New England Journal of Medicine · 468
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
2022 · Jill M. Ferdinands, Suchitra Rao, et al. · MMWR Morbidity and Mortality Weekly Report · 435
PDF
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
2022 · Mark G. Thompson, Karthik Natarajan, et al. · MMWR Morbidity and Mortality Weekly Report · 398
PDF
Intestinal alkaline phosphatase prevents metabolic syndrome in mice
2013 · Kanakaraju Kaliannan, Sulaiman R. Hamarneh, et al. · Proceedings of the National Academy of Sciences · 262
Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020
2020 · Wesley H. Self, Mark W. Tenforde, et al. · MMWR Morbidity and Mortality Weekly Report · 202
PDF
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study
2022 · Jill M Ferdinands, Suchitra Rao, et al. · BMJ · 185
PDF
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022
2022 · Nicola P. Klein, Melissa S. Stockwell, et al. · MMWR Morbidity and Mortality Weekly Report · 179
PDF
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021
2021 · Peter J. Embi, Matthew E. Levy, et al. · MMWR Morbidity and Mortality Weekly Report · 172
A Public Health Research Agenda for Managing Infodemics: Methods and Results of the First WHO Infodemiology Conference
2021 · Neville Calleja, AbdelHalim AbdAllah, et al. · JMIR Infodemiology · 167
PDF
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022
2022 · Ruth Link-Gelles, Matthew E. Levy, et al. · MMWR Morbidity and Mortality Weekly Report · 126
PDF
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Reactive Antibodies: December 2019–January 2020
2020 · Sridhar V Basavaraju, Monica E Patton, et al. · Clinical Infectious Diseases · 110
PDF
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022
2022 · Mark W. Tenforde, Zachary A. Weber, et al. · MMWR Morbidity and Mortality Weekly Report · 104
PDF
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023
2023 · Ruth Link-Gelles, Zachary A. Weber, et al. · MMWR Morbidity and Mortality Weekly Report · 95
PDF
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021
2021 · Catherine H. Bozio, Shaun J. Grannis, et al. · MMWR Morbidity and Mortality Weekly Report · 91
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods
2023 · Ruth Link-Gelles, Matthew E. Levy, et al. · JAMA Network Open · 83
PDF
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022
2022 · Amadea Britton, Peter J. Embi, et al. · MMWR Morbidity and Mortality Weekly Report · 82
Intestinal alkaline phosphatase inhibits the proinflammatory nucleotide uridine diphosphate
2013 · Angela K. Moss, Sulaiman R. Hamarneh, et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 49
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults — VISION Network, 10 States, December 2021–March 2022
2022 · Karthik Natarajan, Namrata Prasad, et al. · MMWR Morbidity and Mortality Weekly Report · 47
PDF
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022
2023 · Mark W. Tenforde, Zachary A. Weber, et al. · MMWR Morbidity and Mortality Weekly Report · 46
PDF
Prevention of antibiotic‐associated metabolic syndrome in mice by intestinal alkaline phosphatase
2016 · K. P. Economopoulos, N. L. Ward, et al. · Diabetes Obesity and Metabolism · 39
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19—VISION Network, 10 States, June 2021–March 2023
2023 · Eric P Griggs, Patrick K Mitchell, et al. · Clinical Infectious Diseases · 27
PDF
Influenza Vaccine Effectiveness Against Influenza A–Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022–2023
2023 · Mark W Tenforde, Zachary A Weber, et al. · The Journal of Infectious Diseases · 25
PDF
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021–2022 Season, VISION Network
2023 · Mark W Tenforde, Zachary A Weber, et al. · The Journal of Infectious Diseases · 23
PDF
A rapid qualitative assessment of barriers associated with demand and uptake of health facility-based childhood immunizations and recommendations to improve immunization service delivery in Sokoto State, Northwest Nigeria, 2017.
2021 · Neetu Abad, Belinda Vernyuy Uba, et al. · PubMed · 21
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents
2023 · Nicola P. Klein, Maria Demarco, et al. · PEDIATRICS · 20
Works count: 57
Citation count: 3,647
H-index: 23
I10-index: 34
Year
Topic
Type